We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Life Science REIT (LABS) ORD GBP0.01

Sell:38.60p Buy:39.00p 0 Change: 0.1p (0.26%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:38.60p
Buy:39.00p
Change: 0.1p (0.26%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:38.60p
Buy:39.00p
Change: 0.1p (0.26%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Life Science REIT plc is a closed-ended real estate investment trust. The Company’s investment objective is to provide shareholders with an attractive level of total return. It seeks to invests in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The Company retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. It also includes purchasing or developing buildings that are leased or intended to be leased to occupiers providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. Its investment adviser is Ironstone Asset Management Limited.

Important dates

Future events
There are no future events available.
Past events
Interim dividend payment date 31 October 2024 31/10/24
Interim ex-dividend date 03 October 2024 03/10/24
Interim results 26 September 2024 26/09/24
AGM 23 May 2024 23/05/24
Interim dividend payment date 13 May 2024 13/05/24
Interim ex-dividend date 04 April 2024 04/04/24
Final results 26 March 2024 26/03/24

General stock information

EPIC:
LABS
ISIN:
GB00BP5X4Q29
Market cap:
£135.10 million
Shares in issue:
350.00 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE All Share,FTSE Small Cap

Contact details

Address:
55 Wells Street
LONDON
W1T 3PT
United Kingdom
Telephone:
+44 (01392) 477500
Website:
https://lifesciencereit.co.uk/

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.